Prescribing Information | GileadPro

This website is developed and funded by Gilead Sciences Ltd and intended for healthcare professionals in the United Kingdom.

Cell Therapy Prescribing Information
Prescribing information for Yescarta® ▼ (axicabtagene ciloleucel)
Prescribing information for Tecartus® ▼ (brexucabtagene autoleucel)

Gilead Sciences Ltd. is not responsible for third-party site content, except for information we have verified and provided.

Stay up to date

Receive email updates from Gilead, including promotional communications.

Register

April 2025 UKI-TEC-0032

Adverse events should be reported

Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or via the Yellow Card app (download from the Apple App Store or Google Play Store). Adverse events should also be reported to Gilead to [email protected] or +44 (0) 1223 897500.